NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization.

Documenti analoghi

• Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.
  di: Benjamin, C W, et al.
  Pubblicazione: (1987)
• Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene.
  di: Tarpley, W G, et al.
  Pubblicazione: (1986)
• Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene.
  di: Lin, A H, et al.
  Pubblicazione: (1988)
• NIH-3T3 cells transformed with a ras oncogene exhibit a protein kinase C-mediated inhibition of agonist-stimulated Ca2+ inflow.
  di: Polverino, A J, et al.
  Pubblicazione: (1990)
• Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
  di: Kuzumaki, N, et al.
  Pubblicazione: (1989)